Avant Diagnostics, Inc., a diagnostic company, focuses on the commercialization of a series of proprietary microarray-based diagnostic tests that provide early detection of cancers, neurodegenerative diseases, and other chronic and severe disease states. The company’s product is OvaDxÒ, a noninvasive proteomics diagnostic screening test for the early detection of ovarian cancer. The company was founded in 2009 and is headquartered in Scottsdale, Arizona.